ResearcherSt. John's UniversityActive in the last 2 years
Vikas V. Dukhande
Matched on ORCID iD 0000-0002-9288-715X; OpenAlex author ID A5038033542. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 5
2020: 1 paper · 2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper
Papers 3
- Synergistic Efficacy of CDK4/6 Inhibitor Abemaciclib and HDAC Inhibitor Panobinostat in Pancreatic Cancer Cells. Last author DOI 10.3390/cancers16152713↗
- In vitro assessment of a synergistic combination of gemcitabine and zebularine in pancreatic cancer cells. Co-author DOI 10.1016/j.yexcr.2021.112660↗
- Nanoformulation of PROteolysis TArgeting Chimera targeting 'undruggable' c-Myc for the treatment of pancreatic cancer. Co-author DOI 10.2217/nnm-2020-0156↗
Closest collaborators
The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Ketan R. Patel · 3 shared papers, 2020–2024 · strength 0.56
- Paper Synergistic Efficacy of CDK4/6 Inhibitor Abemaciclib and HDAC Inhibitor Panobinostat in Pancreatic Cancer Cells. DOI 10.3390/cancers16152713↗
- Paper In vitro assessment of a synergistic combination of gemcitabine and zebularine in pancreatic cancer cells. DOI 10.1016/j.yexcr.2021.112660↗
- Paper Nanoformulation of PROteolysis TArgeting Chimera targeting 'undruggable' c-Myc for the treatment of pancreatic cancer. DOI 10.2217/nnm-2020-0156↗
- Shraddha P. Bhutkar · 2 shared papers, 2021–2024 · strength 0.43
- Aishwarya L. Saraswat · 2 shared papers, 2020–2021 · strength 0.31
- Manali Patki · 2 shared papers, 2020–2021 · strength 0.31
- Anjali Yadav · 1 shared paper, 2024 · strength 0.26
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.